Is the price fair?
What COO's price assumes
Cooper Companies (The) trades at 57.9× earnings against 40.2× for the median Medical Instruments & Supplies name, more expensive than its own group.
57.9
Trailing P/E · Medical Instruments & Supplies median 40.2 · 1.44× the median: the market pays up for this one
- Price / sales
- 2.90
Price / sales · as of 2026-Q2
- Free cash flow yield
- 4.4%
Free cash flow yield · Medical Instruments & Supplies median 3.7%
- Growth the price implies
- +7.2%
Growth the price implies · The price pays for +7.2% free cash flow growth a year for a decade; the business has delivered +14% a year over the last three.
Details›
- Price / book2026-Q2
- 1.49
- EV / EBIT2026-Q2
- 28.1
- EV / sales2026-Q2
- 3.31
- Healthcare median P/E362 names
- 29.9
- Medical Instruments & Supplies median P/E29 names
- 40.2
- Free cash flow, trailing twelve months
- $570M
- Market capitalisation
- $12.9B
- 3-year revenue growth
- +7.3%
- 3-year free cash flow growth
- +14%
| Method | Per share |
|---|---|
| What its own history would imply | not meaningful, 41.6× today against a 16.7× median |
| 52-week range | $58.98 – $84.32 |
| Today | $67.70 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Instruments & Supplies
The closest names by size in the same industry